<unk>  is contraindicated in individuals with a history of substance use disorder, heart disease, or severe agitation or anxiety, or in individuals currently experiencing arteriosclerosis, glaucoma, hyperthyroidism, or severe hypertension. The FDA states that individuals who have experienced hypersensitivity reactions to other stimulants in the past or are currently taking monoamine oxidase inhibitors should not take<unk> . The FDA also advises individuals with bipolar disorder, depression, elevated blood pressure, liver or kidney problems, mania, psychosis, Raynaud's phenomenon, seizures, thyroid problems, tics, or Tourette syndrome to monitor their symptoms while taking<unk> . Due to the potential for stunted growth, the FDA advises monitoring the height and weight of growing children and adolescents during treatment.
Methamphetamine
Benzphetamine
Amphetamine
Benzyl alcohol
Benzocaine
Cannabis
Cannabis 
Nicotine